News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
York Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/27/2023 |
4
| York Michael (Chief Business Officer) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 107,054 shares
@ $0.4141, valued at
$44.3k
|
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| York Michael (VP, Corporate Development) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 36,000 options to buy
@ $4.31, valued at
$155.2k
|
|
| 11/23/2020 |
4
| York Michael (VP, Corporate Development) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 2,662 shares
@ $3, valued at
$8k
|
|
| 02/14/2020 |
4
| York Michael (VP, Corporate Development) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 55,000 options to buy
@ $5.19, valued at
$285.5k
|
|
| 03/01/2019 |
4
| York Michael (VP, Corporate Development) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 45,000 options to buy
@ $3.15, valued at
$141.8k
|
|
| 12/11/2018 |
4
| York Michael (VP, Corporate Development) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Bought 1,500 shares
@ $3.88, valued at
$5.8k
|
|
|
|